Thursday, October 30, 2014
Introducing the 2013 Rx-360 Board of Directors Minimize

Congratulations to the 2013 Rx-360 Board of Directors.  The new positions, in red below, become effective  January 1, 2013:

Chair: 
Al Kentrup, Sandoz

Vice Chair: 
Brian Johnson, Pfizer 

Treasurer:
Martin VanTrieste, Amgen


Supplier Board Members: 

  • Alan Burns, Sartorius
  • Hubertus Folttmann, BASF
  • Frithjof Holtz, Merck KGaA 
  • Guy Villax, Hovione

Finished Product Board Manufacturer Members: 

  • Tom Beil, Sigma Aldrich
  • Janice Berger, AstraZeneca
  • Janice Berman, Takeda
  • Lynne Byers, GSK
  • Thomas Crispin, Bayer
  • Heike Falkenhagen, Boehringer Ingelheim
  • Joseph Famulare, Genentech
  • Jaspret Gill, Baxter
  • Teri Hall, Merck
  • Patricia Latzo, Mylan
  • Mark Paviglianti, Merck
  • Elizabeth Pileggi, Teva
  • Wes Schmidt, Abbott/AbbVie 
  • Melissa Seymour, Biogen Idec   

A special thank you to those members who are finishing up their term:

  • Jack Brinnier, Watson
  • Burghard Freiberg, Merck KGaA
  • Diane Petitti, BMS
  • Paul Smaltz, Avantor 
  

 

2009 © Rx-360